SOLIRIS
- Product NDC
- 25682-001
- 11-digit product format
- 256820001
- Labeler code
- 25682
- Product ID
- 25682-001_25021c88-95e1-42f0-b895-921526b90642
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ECULIZUMAB
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- Alexion Pharmaceuticals Inc.
- Application
- BLA125166
- Marketing category
- BLA
- Marketing start
- 2007-04-02
- Substance
- ECULIZUMAB
- Active strength
- 300 mg/30mL
- Pharmacologic classes
- Complement Inhibitor [EPC], Complement Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- SOLIRIS
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ECULIZUMAB | 300 mg/30mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | A3ULP0F556 |
| Rxcui | 700384, 700387 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 25682-001-01 | SOLIRIS | 30 mL in 1 VIAL | INJECTION, SOLUTION, CONCENTRATE | 30 | | 42 |
| 25682-001-01 | SOLIRIS | 1 in 1 CARTON | INJECTION, SOLUTION, CONCENTRATE | 1 | | 42 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ECULIZUMAB | ACTIVE INGREDIENT | A3ULP0F556 | SOLIRIS (ECULIZUMAB) INJECTION, SOLUTION, CONCENTRATE [ALEXION PHARMACEUTICALS INC.] | 20 | |
| ECULIZUMAB | ACTIVE MOIETY | A3ULP0F556 | SOLIRIS (ECULIZUMAB) INJECTION, SOLUTION, CONCENTRATE [ALEXION PHARMACEUTICALS INC.] | 20 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | SOLIRIS (ECULIZUMAB) INJECTION, SOLUTION, CONCENTRATE [ALEXION PHARMACEUTICALS INC.] | 20 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | SOLIRIS (ECULIZUMAB) INJECTION, SOLUTION, CONCENTRATE [ALEXION PHARMACEUTICALS INC.] | 20 | |
| SODIUM PHOSPHATE, DIBASIC | INACTIVE INGREDIENT | GR686LBA74 | SOLIRIS (ECULIZUMAB) INJECTION, SOLUTION, CONCENTRATE [ALEXION PHARMACEUTICALS INC.] | 20 | |
| SODIUM PHOSPHATE, MONOBASIC | INACTIVE INGREDIENT | 3980JIH2SW | SOLIRIS (ECULIZUMAB) INJECTION, SOLUTION, CONCENTRATE [ALEXION PHARMACEUTICALS INC.] | 20 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | SOLIRIS (ECULIZUMAB) INJECTION, SOLUTION, CONCENTRATE [ALEXION PHARMACEUTICALS INC.] | 20 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 25682-001 | SOLIRIS (ECULIZUMAB) INJECTION, SOLUTION, CONCENTRATE [ALEXION PHARMACEUTICALS INC.] | 42 | Current NDC, Legacy NDC, 2 package rows | 20250311_ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 25682-001-01 | 25682000101 | 1 VIAL in 1 CARTON (25682-001-01) / 30 mL in 1 VIAL | 1 vial | 2007-04-02 | 0000-00-00 | No | No | Current |